Linear atrophoderma of moulin; a mimicker of linear scleroderma


  • Swathi Pitchiammal Vairaprakasam Karnataka Institute of Medical Sciences
  • Ravi Munsing Rathod Karnataka Institute of Medical Sciences
  • Rashmi Laxman Chavan Karnataka Institute of Medical Sciences
  • Sahana Krishnarajanagara Siddalingaiah Karnataka Institute of Medical Sciences.


Linear Atrophoderma of Moulin, Linear sclroderma, Histopathology


Linear atrophoderma of Moulin (LAM) is an acquired, rare and self-limited skin condition. It is characterized by atrophic band-like skin lesions that often show hyperpigmentation and always follow the lines of Blaschko.Lesions in LAM are similar to atrophoderma of Pasini and Pierini but lesions in the latter entity do not follow Blaschko’s lines.The close differential diagnosis of LAM is linear scleroderma. As LAM is a benign condition and does not require active intervention it is important to differentiate it from linear scleroderma which is progressive and requires active management.


Weedon D. The dermis and subcutis. In: Weedon D, editor. Weedon's Skin Pathology. 3rd ed. Edinburgh: Churchil Livingstone Elsevier; 2010. p. 323-24.

Lowell CR. Acquired disorders of dermal connective tissue. In: Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook's Textbook of Dermatology. 9th ed. West Sussex: Wiley Blackwell Publishers; 2016. pp. 96.14–5.

Wongkietkachorn K, Intarasupht J, Srisuttiyakorn C. Linear Atrophoderma of Moulin : A Case Report and Review of the Literature. 2013;10400:11–4.

Manganoni AM, Fusano M, Pavoni L, et al. Linear atrophoderma of Moulin : A rare entity. 2018;84(5):2018–21.

Patrizi A, Venturi M, Neri I, et al. Atrophoderma following lines of Blaschko: An interesting diagnostic dilemma. Linear atrophoderma of Moulin, blaschko linear atrophoderma of Pasini and Pierini or linear morphea. Clin Dermatol 2013; 1:29‑36




How to Cite

Vairaprakasam SP, Rathod RM, Chavan RL, Siddalingaiah SK. Linear atrophoderma of moulin; a mimicker of linear scleroderma. J Pak Assoc Dermatol [Internet]. 2022Apr.10 [cited 2024Jun.17];31(3):560-1. Available from:



Short Communications

Most read articles by the same author(s)